Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment

V Kunzmann, T Ruediger, M Hallek, HK Mueller-Hermelink, Martin Wilhelm* (Last author)

*Corresponding author for this work

    Research output: Contribution to journalLetter to the editorpeer-review

    18 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)1991-1992
    JournalBLOOD
    Volume98
    Issue number6
    DOIs
    Publication statusPublished - 2001

    Keywords

    • CHRONIC LYMPHOCYTIC-LEUKEMIA
    • LEUKOSTASIS

    Cite this